Literature DB >> 24138050

Autosomal dominant hereditary optic neuropathy (ADOA): a review of the genetics and clinical manifestations of ADOA and ADOA+.

P M Skidd1, S Lessell, D M Cestari.   

Abstract

Autosomal dominant hereditary optic atrophy (ADOA), also known as Kjer's syndrome, is a common hereditary cause of progressive bilateral vision loss. Recent advancements in the understanding of the genetics of this condition have revealed that a single gene may account for a large portion of the clinical manifestations in these patients. It has long been recognized that in a not-insignificant number of ADOA patients, a number of "plus" symptoms may follow decades after vision loss. It is important that clinicians recognize the potential link to "plus" manifestations. The goal of this manuscript is to provide for the general ophthalmologist a practical outline of the genetics and clinical manifestations of ADOA and the ADOA+.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24138050     DOI: 10.3109/08820538.2013.825296

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  11 in total

1.  Clinical and genetic features of eight Chinese autosomal-dominant optic atrophy pedigrees with six novel OPA1 pathogenic variants.

Authors:  Huajin Li; Evan M Jones; Hui Li; Lizhu Yang; Zixi Sun; Zhisheng Yuan; Rui Chen; Fangtian Dong; Ruifang Sui
Journal:  Ophthalmic Genet       Date:  2018-06-28       Impact factor: 1.803

2.  Exome sequencing identified a novel de novo OPA1 mutation in a consanguineous family presenting with optic atrophy.

Authors:  Lior Cohen; Shay Tzur; Nitza Goldenberg-Cohen; Concetta Bormans; Doron M Behar; Eyal Reinstein
Journal:  Genet Res (Camb)       Date:  2016-06-06       Impact factor: 1.588

3.  Analysis of Genetic Mutations in a Cohort of Hereditary Optic Neuropathy in Shanghai, China.

Authors:  Dekang Gan; Mengwei Li; Jihong Wu; Xinghuai Sun; Guohong Tian
Journal:  J Ophthalmol       Date:  2017-12-04       Impact factor: 1.909

4.  Processing of OPA1 with a novel N-terminal mutation in patients with autosomal dominant optic atrophy: Escape from nonsense-mediated decay.

Authors:  Aneta Ścieżyńska; Ewelina Ruszkowska; Kamil Szulborski; Katarzyna Rydz; Joanna Wierzbowska; Joanna Kosińska; Marek Rękas; Rafał Płoski; Jacek Paweł Szaflik; Monika Ołdak
Journal:  PLoS One       Date:  2017-08-25       Impact factor: 3.240

5.  Characterization of two novel intronic OPA1 mutations resulting in aberrant pre-mRNA splicing.

Authors:  Ramona Bolognini; Christina Gerth-Kahlert; Mathias Abegg; Deborah Bartholdi; Nicolas Mathis; Veit Sturm; Sabina Gallati; André Schaller
Journal:  BMC Med Genet       Date:  2017-02-28       Impact factor: 2.103

6.  Optimized OPA1 Isoforms 1 and 7 Provide Therapeutic Benefit in Models of Mitochondrial Dysfunction.

Authors:  Daniel M Maloney; Naomi Chadderton; Sophia Millington-Ward; Arpad Palfi; Ciara Shortall; James J O'Byrne; Lorraine Cassidy; David Keegan; Peter Humphries; Paul Kenna; Gwyneth Jane Farrar
Journal:  Front Neurosci       Date:  2020-11-26       Impact factor: 4.677

7.  MCAT Mutations Cause Nuclear LHON-like Optic Neuropathy.

Authors:  Sylvie Gerber; Christophe Orssaud; Josseline Kaplan; Catrine Johansson; Jean-Michel Rozet
Journal:  Genes (Basel)       Date:  2021-04-02       Impact factor: 4.096

8.  First Description of Inheritance of a Postzygotic OPA1 Mosaic Variant.

Authors:  Svenja Alter; Navid Farassat; Sebastian Küchlin; Wolf A Lagrèze; Judith Fischer
Journal:  Genes (Basel)       Date:  2022-03-08       Impact factor: 4.096

9.  First report of OPA1 screening in Greek patients with autosomal dominant optic atrophy and identification of a previously undescribed OPA1 mutation.

Authors:  Smaragda Kamakari; George Koutsodontis; Miltiadis Tsilimbaris; Athanasios Fitsios; Georgia Chrousos
Journal:  Mol Vis       Date:  2014-05-27       Impact factor: 2.367

10.  A Missense Mutation in OPA1 Causes Dominant Optic Atrophy in a Chinese Family.

Authors:  Shaoyi Mei; Xiaosheng Huang; Lin Cheng; Shiming Peng; Tianhui Zhu; Liang Chen; Yan Wang; Jun Zhao
Journal:  J Ophthalmol       Date:  2019-11-03       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.